価格表

在庫・価格 : 2024年05月18日 11時31分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Survivin, Rabbit-Poly
データシート※最新のデータシートでない場合があります
NB500-201SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥43,000
(未発注)
追加

在庫・価格 : 2024年05月18日 11時31分 現在

Anti-Survivin, Rabbit-Poly

  • 商品コード:NB500-201SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥43,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yamazaki H et al. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models. Res. Vet. Sci. 2015 Apr;99:137-44
Yamazaki H et al
2015/01/01
Species: Canine, Applications: IHC-P PubMed
2 Cornago M et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis 2014;5:e1435
Cornago M et al
2014/01/01
Species: Human, Applications: WB, ICC/IF PubMed
3 Cao XQ et al. MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis. Asian Pac. J. Cancer Prev. 2014;15(13):5271-6
Cao XQ et al
2014/01/01
Species: Human, Applications: WB, IHC-P PubMed
4 Althoff K et al. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int. J. Cancer 2015 Mar;136(6):1308-20
Althoff K et al
2015/01/01
Species: Human, Applications: ICC/IF PubMed
5 Grazia G et al. Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma. Cell Death Dis 2014;5:e1434
Grazia G et al
2014/01/01
Species: Human, Applications: WB PubMed
6 Ram鱈rez-Labrada A et al. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clin Transl Oncol 2014 Jul;
Ram鱈rez-Labrada A et al
2014/01/01
Species: Human, Applications: WB PubMed
7 D鱈az A et al. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am. J. Surg. Pathol. 2011 Nov;35(11):1733-42
D鱈az A et al
2011/01/01
Species: Human, Applications: IHC PubMed
8 Erba HP et al. Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML). Invest New Drugs 2013 Feb;
Erba HP et al
2013/01/01
Species: Human, Applications: ELISA PubMed
9 Semrau R et al. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. Head Neck 2013 Sep;35(
Semrau R et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
10 Asanuma H et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 2005 Dec;65(23):
Asanuma H et al
2005/01/01
Applications: PubMed
11 Miranda MB et al. Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells. Leukemia 2003 Feb;17(2):390-400
Miranda MB et al
2003/01/01
Applications: PubMed
12 Thirunavukkarasu M et al. Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxid. Redox Signal. 2008 Aug;10(8):1475-84
Thirunavukkarasu M et al
2008/01/01
Applications: PubMed
13 Niibe Y et al. Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501). Eur. J. Gynaecol. Oncol. 2010;31(5):491-6
Niibe Y et al
2010/01/01
Applications: PubMed
14 Robles AI et al. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines. Clin. Cancer Res. 2006 Nov;12(21):6547-56
Robles AI et al
2006/01/01
Applications: PubMed
15 Honegger A et al. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int. J. Cancer 2013 Oct;133(7):1631-42
Honegger A et al
2013/01/01
Species: Human, Applications: WB PubMed
16 Chiou SK et al. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury. Biochem. Pharmacol. 2011 Jun;81(11):1317-23
Chiou SK et al
2011/01/01
Applications: PubMed
17 Finkelstein SE et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int. J. Radiat. Oncol. Biol. Phys. 2012 Feb;82(2):924-32
Finkelstein SE et al
2012/01/01
Applications: PubMed
18 AbouAlaiwi WA et al. Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation. Hum. Mol. Genet. 2011 Jan;20(2):354-67
AbouAlaiwi WA et al
2011/01/01
Species: Mouse, Applications: WB PubMed
19 Lou Y et al. Oral administration of caffeine during voluntary exercise markedly decreases tissue fat and stimulates apoptosis and cyclin B1 in UVB-treated skin of hairless p53-knockout mice. Carcinogenesis 2010 Apr;31(4):671-8
Lou Y et al
2010/01/01
Applications: PubMed
20 Kan CY et al. Upregulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16INK4a and confers resistance to oxidative stress. J. Biol. Chem. 2013 Feb;
Kan CY et al
2013/01/01
Species: Human, Applications: WB PubMed
21 Bongiovanni L et al. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma. BMC Vet. Res. 2012;8:78
Bongiovanni L et al
2012/01/01
Species: Canine, Applications: IHC PubMed
22 Lubet RA et al. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin. Carcinogenesis 2005 Mar;26(3):571-8
Lubet RA et al
2005/01/01
Species: Mouse, Applications: IHC-P PubMed
23 Lechler P et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am. J. Pathol. 2007 Nov;171(5):1483-98
Lechler P et al
2007/01/01
Species: Human, Rat, Mouse, Applications: IHC-P PubMed
24 Pannone G et al. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Thyroid 2014 Mar;24(3):511-9
Pannone G et al
2014/01/01
Applications: PubMed
25 Hebb AL et al. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult. Scler. 2008 Jun;14(5):577-94
Hebb AL et al
2008/01/01
Applications: PubMed
26 Saxena P et al. PSA regulates androgen receptor expression in prostate cancer cells. Prostate 2012 May;72(7):769-76
Saxena P et al
2012/01/01
Species: Human, Applications: WB PubMed
27 MacCallum DE et al. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res. 2005 Jun;65(12):5399-407
MacCallum DE et al
2005/01/01
Applications: PubMed
28 Kim SH et al. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 2011 Jun;4(6):897-906
Kim SH et al
2011/01/01
Species: Human, Mouse, Applications: WB, IHC PubMed
29 Seo SI et al. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clin. Cancer Res. 2008 Oct;14(19):6198-206
Seo SI et al
2008/01/01
Applications: PubMed
30 Kunze D et al. Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy. Int J Mol Sci 2013;14(6):12297-312
Kunze D et al
2013/01/01
Species: Human, Applications: WB PubMed
31 Takagi K et al. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment. Br. J. Cancer 2013 Jul;109(1):100-8
Takagi K et al
2013/01/01
Species: Human, Applications: IHC PubMed
32 Zhang L et al. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2008 Dec;105(49):19532-7
Zhang L et al
2008/01/01
Applications: PubMed
33 de Souza HS et al. Increased Levels of Survivin, via Association With Heat Shock Protein 90, in Mucosal T Cells From Patients With Crohn"s Disease. Gastroenterology 2012 Oct;143(4):1017-1026.e9
de Souza HS et al
2012/01/01
Species: Human, Applications: IHC, ICC/IF, IP PubMed
34 Moiseeva EP et al. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol. Cancer Ther. 2007 Nov;6(11):3071-9
Moiseeva EP et al
2007/01/01
Applications: PubMed
35 D鱈az R et al. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas. Genes Chromosomes Cancer 2010 Dec;49(12):1135-42
D鱈az R et al
2010/01/01
Species: Human, Applications: WB PubMed
36 Fu DR et al. Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy. J. Vet. Med. Sci. 2014 Aug;
Fu DR et al
2014/01/01
Species: Canine, Applications: IHC-P PubMed
37 Hori M et al. The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer. PLoS ONE 2013;8(2):e55710
Hori M et al
2013/01/01
Species: Human, Hamster, Applications: WB PubMed
38 Yakirevich E et al. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Hum. Pathol. 2012 Jun;43(6):865-73
Yakirevich E et al
2012/01/01
Species: Human, Applications: IHC PubMed
39 Bongiovanni L et al. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours. Vet. Dermatol. 2013 Feb;24(1):195-203.e42-3
Bongiovanni L et al
2013/01/01
Species: Canine, Applications: IHC-P PubMed
40 Felisiak-Golabek A et al. Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients. J Ovarian Res 2011;4(1):20
Felisiak-Golabek A et al
2011/01/01
Applications: PubMed
41 Velmurugan B et al. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm. Res. 2010 Oct;27(10):2085-97
Velmurugan B et al
2010/01/01
Species: Human, Applications: IHC-P PubMed
42 Fortugno P et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell. Sci. 2002 Feb;115(Pt 3):575-85
Fortugno P et al
2002/01/01
Species: Human, Applications: IP, WB, ICC/IF PubMed
43 Hauf S et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 2003 Apr;161(2):281-94
Hauf S et al
2003/01/01
Applications: PubMed
44 Tyagi A et al. Differential effect of grape seed extract against human non-small-cell lung cancer cells: the role of reactive oxygen species and apoptosis induction. Nutr Cancer 2013;65 Suppl 1:44-53
Tyagi A et al
2013/01/01
Species: Human, Applications: WB PubMed
45 Lechler P et al. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer 2011;11:120
Lechler P et al
2011/01/01
Applications: PubMed
46 Tyagi A et al. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Mol. Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55
Tyagi A et al
2007/01/01
Applications: PubMed
47 Jacob NK et al. Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation. Onco Targets Ther 2012;5:7-20
Jacob NK et al
2012/01/01
Species: Human, Applications: WB PubMed
48 Knauer SK et al. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum. Mutat. 2013 Feb;34(2):395-404
Knauer SK et al
2013/01/01
Species: Human, Applications: IHC PubMed
49 Fossey SL et al. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 2011;11:112
Fossey SL et al
2011/01/01
Species: Human, Canine, Applications: WB PubMed
50 Ferrer A et al. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. Oncogene 2004 Nov;23(55):8941-9
Ferrer A et al
2004/01/01
Applications: PubMed
51 Wheatley SP et al. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 2001 Jun;11(11):886-90
Wheatley SP et al
2001/01/01
Species: Human, Applications: ICC/IF PubMed
52 Zhu L et al. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 2001 Nov;508(3):369-74
Zhu L et al
2001/01/01
Applications: PubMed
53 Sun Y et al. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation. Curr Cancer Drug Targets 2013 Jan;13(1):57-68
Sun Y et al
2013/01/01
Species: Human, Applications: WB PubMed
54 El Ghamrasni S et al. Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genet. 2011 May;7(5):e1001385
El Ghamrasni S et al
2011/01/01
Applications: PubMed
55 Adler M et al. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 2009 Apr;30(4):711-9
Adler M et al
2009/01/01
Species: Rat, Applications: IHC-P PubMed
56 Yi XP et al. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. Mol Med Rep 2015 Jul;12(1):601-8
Yi XP et al
2015/01/01
Applications: PubMed
57 Wuttig D et al. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition? Int. J. Oncol. 2007 Jun;30(6):1317-24
Wuttig D et al
2007/01/01
Species: Human, Applications: IHC-P, WB PubMed
58 Jin B et al. Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing β-catenin signaling. Mol. Cancer Ther. 2014 May;13(5):1217-30
Jin B et al
2014/01/01
Species: Human, Applications: WB PubMed
59 Blanc-Brude OP et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 2003 Jul;9(7):2683-92
Blanc-Brude OP et al
2003/01/01
Applications: PubMed
60 Appleyard MV et al. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int. J. Cancer 2009 Jan;124(2):465-72
Appleyard MV et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
61 Dhawan D et al. DNMT1: An emerging target in the treatment of invasive urinary bladder cancer. Urol Oncol 2012 May;
Dhawan D et al
2012/01/01
Species: canine, Applications: WB PubMed
62 Lechler P et al. The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro. BMC Musculoskelet Disord 2011;12:150
Lechler P et al
2011/01/01
Applications: PubMed
63 . ;

Species: Human, Applications: WB PubMed
64 Pennati M et al. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol. Cancer Ther. 2005 Sep;4(9):1328-37
Pennati M et al
2005/01/01
Applications: PubMed
65 Mallikarjuna G et al. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res. 2004 Sep;64(17):6349-56
Mallikarjuna G et al
2004/01/01
Applications: PubMed
66 Matteucci C et al. Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatol. Res. 2013 Sep;
Matteucci C et al
2013/01/01
Species: Human, Applications: ELISA PubMed
67 Dallaglio K et al. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp. Dermatol. 2013 Apr;22(4):255-61
Dallaglio K et al
2013/01/01
Applications: PubMed
68 Chao C et al. Epstein-Barr Virus Infection and Expression of B-cell Oncogenic Markers in HIV-Related Diffuse Large B-cell Lymphoma. Clin. Cancer Res. 2012 Sep;18(17):4702-4712
Chao C et al
2012/01/01
Species: Human, Applications: IHC PubMed
69 Gnana-Prakasam JP et al. Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2013 Jan;54(1):63-71
Gnana-Prakasam JP et al
2013/01/01
Applications: PubMed
70 Shariat SF et al. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin. Cancer Res. 2009 Nov;15(22):7012-9
Shariat SF et al
2009/01/01
Applications: PubMed
71 Eberhard Y et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 2009 Oct;114(14):3064-73
Eberhard Y et al
2009/01/01
Applications: PubMed
72 Xu Y et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004 Sep;23(9):527-37
Xu Y et al
2004/01/01
Applications: PubMed
73 Slagter-J辰ger JG et al. Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response. Mol Ther Nucleic Acids 2013;2:e91
Slagter-J辰ger JG et al
2013/01/01
Species: Human, Applications: WB PubMed
74 Baba HA et al. Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation. Liver Int. 2009 Apr;29(4):585-92
Baba HA et al
2009/01/01
Species: Rat, Applications: IHC-P, WB PubMed
75 Hahn JY et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J. Biol. Chem. 2006 Oct;281(41):30979-89
Hahn JY et al
2006/01/01
Applications: PubMed
76 Bongiovanni L et al. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions. Vet. Dermatol. 2012 Oct;23(5):394-e73
Bongiovanni L et al
2012/01/01
Species: Canine, Applications: IHC PubMed
77 Lechler P et al. The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells. Calcif. Tissue Int. 2011 Sep;89(3):211-20
Lechler P et al
2011/01/01
Species: Human, Applications: ICC/IF PubMed
78 Dallaglio K et al. Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation. Int J Mol Sci 2013;14(10):19540-55
Dallaglio K et al
2013/01/01
Species: Human, Applications: IHC-P, WB PubMed
79 Lee JH et al. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am. J. Physiol., Cell Physiol. 2009 Feb;296(2):C327-38
Lee JH et al
2009/01/01
Applications: PubMed
80 Chen B et al. Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction. Mol. Biol. Rep. 2012 Jan;39(1):185-91
Chen B et al
2012/01/01
Species: Human, Applications: WB PubMed
81 Yip KW et al. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin. Cancer Res. 2006 Oct;12(19):5726-32
Yip KW et al
2006/01/01
Species: Human, Applications: IHC-P PubMed
82 Niedbala W et al. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(39):15478-83
Niedbala W et al
2007/01/01
Species: Mouse, Applications: FLOW PubMed
83 Zha H et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest. 2004 Feb;84(2):235-44
Zha H et al
2004/01/01
Applications: PubMed
84 Chun KS et al. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol. Carcinog. 2011 Jun;50(6):439-48
Chun KS et al
2011/01/01
Species: Mouse, Applications: WB PubMed
85 Asanuma K et al. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J. Immunol. 2004 Mar;172(6):3922-9
Asanuma K et al
2004/01/01
Applications: PubMed
86 Jia L et al. ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Res. 2009 Jun;69(12):4974-82
Jia L et al
2009/01/01
Applications: WB PubMed
87 Jiang C et al. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. World J. Gastroenterol. 2012 Jun;18(23):2956-65
Jiang C et al
2012/01/01
Species: Human, Applications: WB PubMed
88 Talbot DC et al. Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. Clin. Cancer Res. 2010 Dec;16(24):6150-8
Talbot DC et al
2010/01/01
Applications: PubMed
89 Alaggio R et al. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS ONE 2013;8(11):e80456
Alaggio R et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
90 Augello C et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 2009;9:125
Augello C et al
2009/01/01
Species: Human, Applications: IHC PubMed
91 Artesi M et al. Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro-oncology 2014 Aug;
Artesi M et al
2014/01/01
Species: Human, Applications: WB PubMed
92 Taniguchi F et al. The Cellular Inhibitor of Apoptosis Protein-2 is a Possible Target of Novel Treatment for Endometriosis. Am. J. Reprod. Immunol. 2014 Mar;71(3):278-85
Taniguchi F et al
2014/01/01
Species: Human, Applications: WB PubMed
93 Svec J et al. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm. Bowel Dis. 2010 Jul;16(7):1127-37
Svec J et al
2010/01/01
Species: Human, Applications: IHC PubMed
94 Page BD et al. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain. Bioorg. Med. Chem. Lett. 2011 Sep;21(18):5605-9
Page BD et al
2011/01/01
Applications: PubMed
95 Deep G et al. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis 2007 Jul;28(7):1533-42
Deep G et al
2007/01/01
Applications: PubMed
96 Chakravarti A et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 2002 Feb;20(4):1063-8
Chakravarti A et al
2002/01/01
Species: Human, Applications: WB PubMed
97 Fornaro M et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J. Biol. Chem. 2003 Dec;278(50):50402-11
Fornaro M et al
2003/01/01
Applications: PubMed
98 Chiou SK et al. Nutrient availability alters the effect of autophagy on sulindac sulfide-induced colon cancer cell apoptosis. Gastroenterol Res Pract 2012;2012:897678
Chiou SK et al
2012/01/01
Species: Human, Applications: WB PubMed
99 Lu J et al. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clin. Cancer Res. 2009 Feb;15(4):1326-34
Lu J et al
2009/01/01
Applications: PubMed
100 R端ckert F et al. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010;10:379
R端ckert F et al
2010/01/01
Species: Human, Applications: WB PubMed
101 Fetz V et al. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int. J. Cancer 2009 May;124(9):2033-41
Fetz V et al
2009/01/01
Species: Human, Applications: IHC-P, ICC/IF, WB PubMed
102 Faderl S et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 2003 Jul;102(2):630-7
Faderl S et al
2003/01/01
Applications: PubMed
103 Goel HL et al. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase1. J. Cell. Physiol. 2013 Jan;
Goel HL et al
2013/01/01
Species: Human, Applications: WB PubMed
104 Khan S et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br. J. Cancer 2009 Apr;100(7):1073-86
Khan S et al
2009/01/01
Species: Human, Applications: WB PubMed
105 Zeitlin SG et al. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J. Cell Biol. 2001 Dec;155(7):1147-57
Zeitlin SG et al
2001/01/01
Species: Human, Applications: WB, ICC/IF PubMed
106 Ebata A et al. Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma. Endocr. Relat. Cancer 2012 Aug;19(4):485-96
Ebata A et al
2012/01/01
Species: Human, Applications: IHC PubMed
107 Altura RA et al. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br. J. Cancer 2003 Nov;89(9):1743-9
Altura RA et al
2003/01/01
Applications: PubMed
108 Zhang M et al. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients. Target Oncol 2013 Nov;
Zhang M et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
109 Beltrami E et al. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 2004 Jan;279(3):2077-84
Beltrami E et al
2004/01/01
Applications: PubMed
110 Lee CW et al. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008 Jul;68(13):5273-81
Lee CW et al
2008/01/01
Applications: PubMed
111 Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br. J. Cancer 2002 Jul;87(1):91-7
Yu J et al
2002/01/01
Species: Human, Applications: WB, IHC-P PubMed
112 Kavitha CV et al. Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PLoS ONE 2011;6(8):e22745
Kavitha CV et al
2011/01/01
Applications: PubMed
113 Song KY et al. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn. J. Clin. Oncol. 2009 May;39(5):290-6
Song KY et al
2009/01/01
Applications: PubMed
114 Krysan K et al. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep;64(18):6359-62
Krysan K et al
2004/01/01
Applications: PubMed
115 Amin HM et al. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 2004 Jul;23(32):5426-34
Amin HM et al
2004/01/01
Applications: PubMed
116 Symes JC et al. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel. Mol. Cancer Ther. 2008 Sep;7(9):3018-28
Symes JC et al
2008/01/01
Applications: PubMed
117 Borghouts C et al. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol. Cancer Res. 2008 Feb;6(2):267-81
Borghouts C et al
2008/01/01
Applications: PubMed
118 Yamazaki H et al. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines. PLoS ONE 2013;8(11):e79810
Yamazaki H et al
2013/01/01
Species: Canine, Applications: WB PubMed
119 Chiappara G et al. The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD. Biochim. Biophys. Acta 2013 Oct;1832(10):1473-81
Chiappara G et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
120 Dai Y et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin. Cancer Res. 2008 Dec;14(23):7701-10
Dai Y et al
2008/01/01
Applications: PubMed
121 Kunze D et al. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Int. J. Oncol. 2008 May;32(5):1049-56
Kunze D et al
2008/01/01
Species: Mouse, Applications: IHC-P PubMed
122 Kim EY et al. TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 2006 Jan;176(2):1026-35
Kim EY et al
2006/01/01
Species: Mouse, Applications: FLOW, ICC/IF PubMed
123 Komuro Y et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod. Pathol. 2004 Feb;17(2):264
Komuro Y et al
2004/01/01
Applications: PubMed
124 Zhang C et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin. Cancer Res. 2002 May;8(5):1234-40
Zhang C et al
2002/01/01
Applications: PubMed
125 Vischioni B et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann. Oncol. 2004 Nov;15(11):1654-60
Vischioni B et al
2004/01/01
Applications: PubMed
126 Mellai M et al. Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res. ;28(1A):109-18
Mellai M et al
Species: Human, Applications: IHC-P PubMed
127 Balkhi MY et al. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation. Exp. Hematol. 2008 Nov;36(11):1449-60
Balkhi MY et al
2008/01/01
Species: Mouse, Applications: WB PubMed
128 Skoufias DA et al. Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed. J. Cell Biol. 2007 Nov;179(4):671-85
Skoufias DA et al
2007/01/01
Applications: PubMed
129 Ramp U et al. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br. J. Cancer 2003 Jun;88(11):1800-7
Ramp U et al
2003/01/01
Applications: PubMed
130 Francisco R et al. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett. 2012 May;318(1):42-52
Francisco R et al
2012/01/01
Species: Human, Applications: WB PubMed
131 Chakravarti A et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 2004 Sep;23(45):7494-506
Chakravarti A et al
2004/01/01
Applications: PubMed
132 Cheng CW et al. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Am. J. Pathol. 2013 Mar;182(3):765-75
Cheng CW et al
2013/01/01
Applications: PubMed
133 Kirkiles-Smith NC et al. IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J. Immunol. 2004 Feb;172(3):1391-6
Kirkiles-Smith NC et al
2004/01/01
Applications: PubMed
134 Johnson VL et al. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. J. Cell. Sci. 2004 Mar;117(Pt 8):1577-89
Johnson VL et al
2004/01/01
Applications: PubMed
135 Singh RP et al. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin. Cancer Res. 2008 Jan;14(1):300-8
Singh RP et al
2008/01/01
Applications: PubMed
136 Scrittori L et al. A small C-terminal sequence of Aurora B is responsible for localization and function. Mol. Biol. Cell 2005 Jan;16(1):292-305
Scrittori L et al
2005/01/01
Species: Human, Applications: ICC/IF, WB PubMed
137 Engels K et al. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res. 2008 Jul;68(13):5159-66
Engels K et al
2008/01/01
Applications: PubMed
138 Kindt N et al. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J. 2008 Feb;22(2):510-21
Kindt N et al
2008/01/01
Applications: PubMed
139 Khan S et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014;14:176
Khan S et al
2014/01/01
Species: Human, Applications: WB, IHC-P PubMed
140 Blanc-Brude OP et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat. Med. 2002 Sep;8(9):987-94
Blanc-Brude OP et al
2002/01/01
Species: Rat, Applications: WB, IHC-Fr, ICC/IF PubMed
141 Martinez A et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am. J. Pathol. 2004 Feb;164(2):501-10
Martinez A et al
2004/01/01
PubMed
142 Schaue D et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin. Cancer Res. 2008 Aug;14(15):4883-90
Schaue D et al
2008/01/01
PubMed
143 Chock KL et al. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Cancer Res. 2010 Nov;70(21):8782-91
Chock KL et al
2010/01/01
Species: Human, Applications: WB PubMed
144 Min L et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 2012 Nov;14(11):1203-11
Min L et al
2012/01/01
Species: Human, Applications: IHC PubMed
145 Kim EY et al. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth. J. Immunol. 2009 Nov;183(10):6051-7
Kim EY et al
2009/01/01
PubMed
146 Liu T et al. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004 Jan;23(1):39-48
Liu T et al
2004/01/01
PubMed
147 Gong J et al. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells. Endocrinology 2007 Sep;148(9):4489-99
Gong J et al
2007/01/01
PubMed
148 Chen Y et al. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells. Oncogene 2003 Aug;22(32):4964-72
Chen Y et al
2003/01/01
PubMed
149 Maxia C et al. Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. Mol. Vis. 2009;15:458-63
Maxia C et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
150 Neef R et al. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol. 2003 Sep;162(5):863-75
Neef R et al
2003/01/01
PubMed
151 Giodini A et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 2002 May;62(9):2462-7
Giodini A et al
2002/01/01
Species: Human PubMed
152 Rudkowski JC et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2004 Apr;286(4):L793-800
Rudkowski JC et al
2004/01/01
Species: Rat, Applications: WB PubMed
153 Qanungo S et al. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002 Jun;21(26):4149-57
Qanungo S et al
2002/01/01
PubMed
154 Guha M et al. Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res. 2009 Jun;69(12):4954-8
Guha M et al
2009/01/01
PubMed
155 Qi G et al. Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol. Rep. 2009 Sep;22(3):557-62
Qi G et al
2009/01/01
Species: Human, Applications: WB PubMed
156 Gassmann R et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 2004 Jul;166(2):179-91
Gassmann R et al
2004/01/01
PubMed
157 Knauer SK et al. An otoprotective role for the apoptosis inhibitor protein survivin. Cell Death Dis 2010;1:e51
Knauer SK et al
2010/01/01
Species: Guinea Pig, Applications: IHC-P PubMed
158 Sayeed A et al. IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels. PLoS ONE 2013;8(10):e76513
Sayeed A et al
2013/01/01
PubMed
159 Mahotka C et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002 Dec;9(12):1334-42
Mahotka C et al
2002/01/01
PubMed
160 Li L et al. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin. Cancer Res. 2013 Dec;19(24):6703-15
Li L et al
2013/01/01
Species: Human, Applications: WB PubMed
161 Vogt N et al. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo. Leuk. Lymphoma 2014 Nov;:1-7
Vogt N et al
2014/01/01
Species: Human, Applications: ICC/IF PubMed
162 Kang BH et al. Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem. 2006 Aug;281(34):24721-7
Kang BH et al
2006/01/01
PubMed
163 Huang H et al. Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J. Cell Biol. 2007 May;177(3):413-24
Huang H et al
2007/01/01
PubMed
164 Chen JS et al. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther. 2004 Nov;11(11):740-7
Chen JS et al
2004/01/01
PubMed
165 Carvalho A et al. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell. Sci. 2003 Jul;116(Pt 14):2987-98
Carvalho A et al
2003/01/01
PubMed
166 Xia F et al. A survivin-ran complex regulates spindle formation in tumor cells. Mol. Cell. Biol. 2008 Sep;28(17):5299-311
Xia F et al
2008/01/01
PubMed
167 Grabowski P et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 2003 Jan;88(1):115-9
Grabowski P et al
2003/01/01
PubMed
168 Wimmershoff J et al. Immunohistochemical detection of survivin in canine lymphoma. J. Comp. Pathol. 2010 May;142(4):311-22
Wimmershoff J et al
2010/01/01
Species: Canine, Applications: IHC PubMed
169 Wang F et al. Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation. J. Cell Biol. 2012 Oct;199(2):251-68
Wang F et al
2012/01/01
PubMed
170 Xia M et al. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene 2011 Jan;30(3):346-55
Xia M et al
2011/01/01
PubMed
171 Honda R et al. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 2003 Aug;14(8):3325-41
Honda R et al
2003/01/01
PubMed
172 Geddis AE et al. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood 2004 Aug;104(4):1017-24
Geddis AE et al
2004/01/01
Species: Mouse, Human, Applications: ICC/IF PubMed
173 Schlette EJ et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J. Clin. Oncol. 2004 May;22(9):1682-8
Schlette EJ et al
2004/01/01
PubMed
174 Kabbarah O et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 2010;5(5):e10770
Kabbarah O et al
2010/01/01
Species: Human, Applications: IHC PubMed
175 Gould Rothberg BE et al. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2009 Apr;101(7):452-74
Gould Rothberg BE et al
2009/01/01
PubMed
176 Connell CM et al. Nuclear survivin has reduced stability and is not cytoprotective. J. Biol. Chem. 2008 Feb;283(6):3289-96
Connell CM et al
2008/01/01
PubMed
177 Wang Z et al. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol. Cancer Ther. 2013 May;12(5):759-67
Wang Z et al
2013/01/01
Species: Mouse, Applications: WB PubMed
178 Fukuda S et al. Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 2006 May;5(5):1087-98
Fukuda S et al
2006/01/01
PubMed
179 Jiang X et al. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin. Cancer Res. 2008 Dec;14(23):7726-32
Jiang X et al
2008/01/01
PubMed
180 Kennedy SM et al. Prognostic importance of survivin in breast cancer. Br. J. Cancer 2003 Apr;88(7):1077-83
Kennedy SM et al
2003/01/01
Species: Human, Applications: IHC-Fr, IHC-P PubMed
181 Hata T et al. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Mol. Cancer Ther. 2005 Oct;4(10):1585-94
Hata T et al
2005/01/01
PubMed
182 Knauer SK et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J. 2007 Jan;21(1):207-16
Knauer SK et al
2007/01/01
PubMed
183 Chen JG et al. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 2003 Nov;63(22):7891-9
Chen JG et al
2003/01/01
PubMed
184 Lu H et al. The Expression and Role of MEKK3 in Renal Clear Cell Carcinoma. Anat Rec (Hoboken) 2014 Nov;
Lu H et al
2014/01/01
PubMed
185 Mao JT et al. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin. Cancer Res. 2006 Jan;12(1):314-20
Mao JT et al
2006/01/01
PubMed
186 Caldas H et al. Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 2007 Feb;109(4):1479-89
Caldas H et al
2007/01/01
PubMed
187 Tecleab A et al. Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle 2013 Feb;12(3):522-32
Tecleab A et al
2013/01/01
Species: Human, Applications: IP PubMed
188 Khan S et al. Survivin is released from cancer cells via exosomes. Apoptosis 2011 Jan;16(1):1-12
Khan S et al
2011/01/01
PubMed
189 Krysan K et al. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J. 2004 Jan;18(1):206-8
Krysan K et al
2004/01/01
PubMed
190 Xia F et al. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 2008 Mar;68(6):1826-33
Xia F et al
2008/01/01
PubMed
191 Fortugno P et al. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. U.S.A. 2003 Nov;100(24):13791-6
Fortugno P et al
2003/01/01
PubMed
192 O"Connor DS et al. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2002 Jul;2(1):43-54
O"Connor DS et al
2002/01/01
Species: Human, Applications: WB, IP PubMed
193 Lo Muzio L et al. Survivin expression in oral squamous cell carcinoma. Br. J. Cancer 2003 Dec;89(12):2244-8
Lo Muzio L et al
2003/01/01
PubMed
194 Ghosh JC et al. Hsp60 regulation of tumor cell apoptosis. J. Biol. Chem. 2008 Feb;283(8):5188-94
Ghosh JC et al
2008/01/01
PubMed
  • No.: 1
  • 文献情報:
    Yamazaki H et al. Survivin suppressor (YM155) enhances chemotherapeutic efficacy against canine histiocytic sarcoma in murine transplantation models. Res. Vet. Sci. 2015 Apr;99:137-44
    Yamazaki H et al
    2015/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Cornago M et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis 2014;5:e1435
    Cornago M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Cao XQ et al. MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis. Asian Pac. J. Cancer Prev. 2014;15(13):5271-6
    Cao XQ et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Althoff K et al. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int. J. Cancer 2015 Mar;136(6):1308-20
    Althoff K et al
    2015/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Grazia G et al. Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma. Cell Death Dis 2014;5:e1434
    Grazia G et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ram鱈rez-Labrada A et al. Two death pathways induced by sorafenib in myeloma cells: Puma-mediated apoptosis and necroptosis. Clin Transl Oncol 2014 Jul;
    Ram鱈rez-Labrada A et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    D鱈az A et al. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am. J. Surg. Pathol. 2011 Nov;35(11):1733-42
    D鱈az A et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Erba HP et al. Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML). Invest New Drugs 2013 Feb;
    Erba HP et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ELISA
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Semrau R et al. Prognostic impact of human papillomavirus status, survivin, and epidermal growth factor receptor expression on survival in patients treated with radiochemotherapy for very advanced nonresectable oropharyngeal cancer. Head Neck 2013 Sep;35(
    Semrau R et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Asanuma H et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 2005 Dec;65(23):
    Asanuma H et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Miranda MB et al. Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L)and XIAP in the prolonged survival of monocytic cells. Leukemia 2003 Feb;17(2):390-400
    Miranda MB et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Thirunavukkarasu M et al. Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxid. Redox Signal. 2008 Aug;10(8):1475-84
    Thirunavukkarasu M et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Niibe Y et al. Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501). Eur. J. Gynaecol. Oncol. 2010;31(5):491-6
    Niibe Y et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Robles AI et al. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines. Clin. Cancer Res. 2006 Nov;12(21):6547-56
    Robles AI et al
    2006/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Honegger A et al. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int. J. Cancer 2013 Oct;133(7):1631-42
    Honegger A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Chiou SK et al. Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury. Biochem. Pharmacol. 2011 Jun;81(11):1317-23
    Chiou SK et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Finkelstein SE et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients. Int. J. Radiat. Oncol. Biol. Phys. 2012 Feb;82(2):924-32
    Finkelstein SE et al
    2012/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    AbouAlaiwi WA et al. Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation. Hum. Mol. Genet. 2011 Jan;20(2):354-67
    AbouAlaiwi WA et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lou Y et al. Oral administration of caffeine during voluntary exercise markedly decreases tissue fat and stimulates apoptosis and cyclin B1 in UVB-treated skin of hairless p53-knockout mice. Carcinogenesis 2010 Apr;31(4):671-8
    Lou Y et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Kan CY et al. Upregulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16INK4a and confers resistance to oxidative stress. J. Biol. Chem. 2013 Feb;
    Kan CY et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Bongiovanni L et al. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma. BMC Vet. Res. 2012;8:78
    Bongiovanni L et al
    2012/01/01
  • 備考:
    Species: Canine, Applications: IHC
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Lubet RA et al. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin. Carcinogenesis 2005 Mar;26(3):571-8
    Lubet RA et al
    2005/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Lechler P et al. The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney. Am. J. Pathol. 2007 Nov;171(5):1483-98
    Lechler P et al
    2007/01/01
  • 備考:
    Species: Human, Rat, Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Pannone G et al. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers. Thyroid 2014 Mar;24(3):511-9
    Pannone G et al
    2014/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Hebb AL et al. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination. Mult. Scler. 2008 Jun;14(5):577-94
    Hebb AL et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Saxena P et al. PSA regulates androgen receptor expression in prostate cancer cells. Prostate 2012 May;72(7):769-76
    Saxena P et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    MacCallum DE et al. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1. Cancer Res. 2005 Jun;65(12):5399-407
    MacCallum DE et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Kim SH et al. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 2011 Jun;4(6):897-906
    Kim SH et al
    2011/01/01
  • 備考:
    Species: Human, Mouse, Applications: WB, IHC
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Seo SI et al. BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells by inducing apoptosis. Clin. Cancer Res. 2008 Oct;14(19):6198-206
    Seo SI et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Kunze D et al. Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy. Int J Mol Sci 2013;14(6):12297-312
    Kunze D et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Takagi K et al. Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment. Br. J. Cancer 2013 Jul;109(1):100-8
    Takagi K et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Zhang L et al. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2008 Dec;105(49):19532-7
    Zhang L et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    de Souza HS et al. Increased Levels of Survivin, via Association With Heat Shock Protein 90, in Mucosal T Cells From Patients With Crohn"s Disease. Gastroenterology 2012 Oct;143(4):1017-1026.e9
    de Souza HS et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC, ICC/IF, IP
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Moiseeva EP et al. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells. Mol. Cancer Ther. 2007 Nov;6(11):3071-9
    Moiseeva EP et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    D鱈az R et al. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas. Genes Chromosomes Cancer 2010 Dec;49(12):1135-42
    D鱈az R et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Fu DR et al. Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy. J. Vet. Med. Sci. 2014 Aug;
    Fu DR et al
    2014/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Hori M et al. The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer. PLoS ONE 2013;8(2):e55710
    Hori M et al
    2013/01/01
  • 備考:
    Species: Human, Hamster, Applications: WB
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Yakirevich E et al. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Hum. Pathol. 2012 Jun;43(6):865-73
    Yakirevich E et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Bongiovanni L et al. Epithelial-to-mesenchymal transition: immunohistochemical investigation of related molecules in canine cutaneous epithelial tumours. Vet. Dermatol. 2013 Feb;24(1):195-203.e42-3
    Bongiovanni L et al
    2013/01/01
  • 備考:
    Species: Canine, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Felisiak-Golabek A et al. Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients. J Ovarian Res 2011;4(1):20
    Felisiak-Golabek A et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Velmurugan B et al. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm. Res. 2010 Oct;27(10):2085-97
    Velmurugan B et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Fortugno P et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J. Cell. Sci. 2002 Feb;115(Pt 3):575-85
    Fortugno P et al
    2002/01/01
  • 備考:
    Species: Human, Applications: IP, WB, ICC/IF
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Hauf S et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 2003 Apr;161(2):281-94
    Hauf S et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Tyagi A et al. Differential effect of grape seed extract against human non-small-cell lung cancer cells: the role of reactive oxygen species and apoptosis induction. Nutr Cancer 2013;65 Suppl 1:44-53
    Tyagi A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Lechler P et al. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer 2011;11:120
    Lechler P et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Tyagi A et al. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice. Mol. Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55
    Tyagi A et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Jacob NK et al. Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation. Onco Targets Ther 2012;5:7-20
    Jacob NK et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Knauer SK et al. Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum. Mutat. 2013 Feb;34(2):395-404
    Knauer SK et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Fossey SL et al. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 2011;11:112
    Fossey SL et al
    2011/01/01
  • 備考:
    Species: Human, Canine, Applications: WB
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Ferrer A et al. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes. Oncogene 2004 Nov;23(55):8941-9
    Ferrer A et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Wheatley SP et al. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase spindle during mitosis. Curr. Biol. 2001 Jun;11(11):886-90
    Wheatley SP et al
    2001/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Zhu L et al. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 2001 Nov;508(3):369-74
    Zhu L et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Sun Y et al. Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation. Curr Cancer Drug Targets 2013 Jan;13(1):57-68
    Sun Y et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    El Ghamrasni S et al. Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer. PLoS Genet. 2011 May;7(5):e1001385
    El Ghamrasni S et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Adler M et al. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 2009 Apr;30(4):711-9
    Adler M et al
    2009/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Yi XP et al. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway. Mol Med Rep 2015 Jul;12(1):601-8
    Yi XP et al
    2015/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Wuttig D et al. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition? Int. J. Oncol. 2007 Jun;30(6):1317-24
    Wuttig D et al
    2007/01/01
  • 備考:
    Species: Human, Applications: IHC-P, WB
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Jin B et al. Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing β-catenin signaling. Mol. Cancer Ther. 2014 May;13(5):1217-30
    Jin B et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Blanc-Brude OP et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 2003 Jul;9(7):2683-92
    Blanc-Brude OP et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Appleyard MV et al. Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model. Int. J. Cancer 2009 Jan;124(2):465-72
    Appleyard MV et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Dhawan D et al. DNMT1: An emerging target in the treatment of invasive urinary bladder cancer. Urol Oncol 2012 May;
    Dhawan D et al
    2012/01/01
  • 備考:
    Species: canine, Applications: WB
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Lechler P et al. The oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitro. BMC Musculoskelet Disord 2011;12:150
    Lechler P et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    . ;

  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Pennati M et al. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol. Cancer Ther. 2005 Sep;4(9):1328-37
    Pennati M et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Mallikarjuna G et al. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res. 2004 Sep;64(17):6349-56
    Mallikarjuna G et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Matteucci C et al. Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatol. Res. 2013 Sep;
    Matteucci C et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ELISA
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Dallaglio K et al. E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro. Exp. Dermatol. 2013 Apr;22(4):255-61
    Dallaglio K et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Chao C et al. Epstein-Barr Virus Infection and Expression of B-cell Oncogenic Markers in HIV-Related Diffuse Large B-cell Lymphoma. Clin. Cancer Res. 2012 Sep;18(17):4702-4712
    Chao C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Gnana-Prakasam JP et al. Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2013 Jan;54(1):63-71
    Gnana-Prakasam JP et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Shariat SF et al. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin. Cancer Res. 2009 Nov;15(22):7012-9
    Shariat SF et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Eberhard Y et al. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood 2009 Oct;114(14):3064-73
    Eberhard Y et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Xu Y et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004 Sep;23(9):527-37
    Xu Y et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Slagter-J辰ger JG et al. Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response. Mol Ther Nucleic Acids 2013;2:e91
    Slagter-J辰ger JG et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Baba HA et al. Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation. Liver Int. 2009 Apr;29(4):585-92
    Baba HA et al
    2009/01/01
  • 備考:
    Species: Rat, Applications: IHC-P, WB
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Hahn JY et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J. Biol. Chem. 2006 Oct;281(41):30979-89
    Hahn JY et al
    2006/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Bongiovanni L et al. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions. Vet. Dermatol. 2012 Oct;23(5):394-e73
    Bongiovanni L et al
    2012/01/01
  • 備考:
    Species: Canine, Applications: IHC
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Lechler P et al. The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells. Calcif. Tissue Int. 2011 Sep;89(3):211-20
    Lechler P et al
    2011/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Dallaglio K et al. Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation. Int J Mol Sci 2013;14(10):19540-55
    Dallaglio K et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P, WB
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Lee JH et al. Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation. Am. J. Physiol., Cell Physiol. 2009 Feb;296(2):C327-38
    Lee JH et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Chen B et al. Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction. Mol. Biol. Rep. 2012 Jan;39(1):185-91
    Chen B et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Yip KW et al. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin. Cancer Res. 2006 Oct;12(19):5726-32
    Yip KW et al
    2006/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Niedbala W et al. Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(39):15478-83
    Niedbala W et al
    2007/01/01
  • 備考:
    Species: Mouse, Applications: FLOW
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Zha H et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab. Invest. 2004 Feb;84(2):235-44
    Zha H et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Chun KS et al. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol. Carcinog. 2011 Jun;50(6):439-48
    Chun KS et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Asanuma K et al. Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells. J. Immunol. 2004 Mar;172(6):3922-9
    Asanuma K et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Jia L et al. ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Res. 2009 Jun;69(12):4974-82
    Jia L et al
    2009/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Jiang C et al. Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion. World J. Gastroenterol. 2012 Jun;18(23):2956-65
    Jiang C et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    Talbot DC et al. Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study. Clin. Cancer Res. 2010 Dec;16(24):6150-8
    Talbot DC et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Alaggio R et al. Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST). PLoS ONE 2013;8(11):e80456
    Alaggio R et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Augello C et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 2009;9:125
    Augello C et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    Artesi M et al. Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy. Neuro-oncology 2014 Aug;
    Artesi M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Taniguchi F et al. The Cellular Inhibitor of Apoptosis Protein-2 is a Possible Target of Novel Treatment for Endometriosis. Am. J. Reprod. Immunol. 2014 Mar;71(3):278-85
    Taniguchi F et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Svec J et al. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia. Inflamm. Bowel Dis. 2010 Jul;16(7):1127-37
    Svec J et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Page BD et al. Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain. Bioorg. Med. Chem. Lett. 2011 Sep;21(18):5605-9
    Page BD et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Deep G et al. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis 2007 Jul;28(7):1533-42
    Deep G et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Chakravarti A et al. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 2002 Feb;20(4):1063-8
    Chakravarti A et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Fornaro M et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J. Biol. Chem. 2003 Dec;278(50):50402-11
    Fornaro M et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Chiou SK et al. Nutrient availability alters the effect of autophagy on sulindac sulfide-induced colon cancer cell apoptosis. Gastroenterol Res Pract 2012;2012:897678
    Chiou SK et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Lu J et al. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance. Clin. Cancer Res. 2009 Feb;15(4):1326-34
    Lu J et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    R端ckert F et al. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis. BMC Cancer 2010;10:379
    R端ckert F et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Fetz V et al. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int. J. Cancer 2009 May;124(9):2033-41
    Fetz V et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P, ICC/IF, WB
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Faderl S et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 2003 Jul;102(2):630-7
    Faderl S et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Goel HL et al. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase1. J. Cell. Physiol. 2013 Jan;
    Goel HL et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Khan S et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br. J. Cancer 2009 Apr;100(7):1073-86
    Khan S et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Zeitlin SG et al. CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J. Cell Biol. 2001 Dec;155(7):1147-57
    Zeitlin SG et al
    2001/01/01
  • 備考:
    Species: Human, Applications: WB, ICC/IF
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Ebata A et al. Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma. Endocr. Relat. Cancer 2012 Aug;19(4):485-96
    Ebata A et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Altura RA et al. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br. J. Cancer 2003 Nov;89(9):1743-9
    Altura RA et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Zhang M et al. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients. Target Oncol 2013 Nov;
    Zhang M et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Beltrami E et al. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 2004 Jan;279(3):2077-84
    Beltrami E et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Lee CW et al. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008 Jul;68(13):5273-81
    Lee CW et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Yu J et al. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br. J. Cancer 2002 Jul;87(1):91-7
    Yu J et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Kavitha CV et al. Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. PLoS ONE 2011;6(8):e22745
    Kavitha CV et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Song KY et al. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma. Jpn. J. Clin. Oncol. 2009 May;39(5):290-6
    Song KY et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Krysan K et al. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004 Sep;64(18):6359-62
    Krysan K et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Amin HM et al. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 2004 Jul;23(32):5426-34
    Amin HM et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Symes JC et al. Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel. Mol. Cancer Ther. 2008 Sep;7(9):3018-28
    Symes JC et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Borghouts C et al. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Mol. Cancer Res. 2008 Feb;6(2):267-81
    Borghouts C et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Yamazaki H et al. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines. PLoS ONE 2013;8(11):e79810
    Yamazaki H et al
    2013/01/01
  • 備考:
    Species: Canine, Applications: WB
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Chiappara G et al. The role of p21 Waf1/Cip1 in large airway epithelium in smokers with and without COPD. Biochim. Biophys. Acta 2013 Oct;1832(10):1473-81
    Chiappara G et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Dai Y et al. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis. Clin. Cancer Res. 2008 Dec;14(23):7701-10
    Dai Y et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Kunze D et al. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Int. J. Oncol. 2008 May;32(5):1049-56
    Kunze D et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Kim EY et al. TNF receptor type 2 (p75) functions as a costimulator for antigen-driven T cell responses in vivo. J. Immunol. 2006 Jan;176(2):1026-35
    Kim EY et al
    2006/01/01
  • 備考:
    Species: Mouse, Applications: FLOW, ICC/IF
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Komuro Y et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod. Pathol. 2004 Feb;17(2):264
    Komuro Y et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Zhang C et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Clin. Cancer Res. 2002 May;8(5):1234-40
    Zhang C et al
    2002/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Vischioni B et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann. Oncol. 2004 Nov;15(11):1654-60
    Vischioni B et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Mellai M et al. Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res. ;28(1A):109-18
    Mellai M et al
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Balkhi MY et al. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation. Exp. Hematol. 2008 Nov;36(11):1449-60
    Balkhi MY et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Skoufias DA et al. Mitosis persists in the absence of Cdk1 activity when proteolysis or protein phosphatase activity is suppressed. J. Cell Biol. 2007 Nov;179(4):671-85
    Skoufias DA et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Ramp U et al. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br. J. Cancer 2003 Jun;88(11):1800-7
    Ramp U et al
    2003/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Francisco R et al. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett. 2012 May;318(1):42-52
    Francisco R et al
    2012/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Chakravarti A et al. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 2004 Sep;23(45):7494-506
    Chakravarti A et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Cheng CW et al. PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Am. J. Pathol. 2013 Mar;182(3):765-75
    Cheng CW et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Kirkiles-Smith NC et al. IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J. Immunol. 2004 Feb;172(3):1391-6
    Kirkiles-Smith NC et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Johnson VL et al. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. J. Cell. Sci. 2004 Mar;117(Pt 8):1577-89
    Johnson VL et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    Singh RP et al. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin. Cancer Res. 2008 Jan;14(1):300-8
    Singh RP et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Scrittori L et al. A small C-terminal sequence of Aurora B is responsible for localization and function. Mol. Biol. Cell 2005 Jan;16(1):292-305
    Scrittori L et al
    2005/01/01
  • 備考:
    Species: Human, Applications: ICC/IF, WB
  • 参照:
    PubMed
  • No.: 137
  • 文献情報:
    Engels K et al. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res. 2008 Jul;68(13):5159-66
    Engels K et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 138
  • 文献情報:
    Kindt N et al. Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J. 2008 Feb;22(2):510-21
    Kindt N et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 139
  • 文献情報:
    Khan S et al. Early diagnostic value of survivin and its alternative splice variants in breast cancer. BMC Cancer 2014;14:176
    Khan S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 140
  • 文献情報:
    Blanc-Brude OP et al. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat. Med. 2002 Sep;8(9):987-94
    Blanc-Brude OP et al
    2002/01/01
  • 備考:
    Species: Rat, Applications: WB, IHC-Fr, ICC/IF
  • 参照:
    PubMed
  • No.: 141
  • 文献情報:
    Martinez A et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am. J. Pathol. 2004 Feb;164(2):501-10
    Martinez A et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 142
  • 文献情報:
    Schaue D et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin. Cancer Res. 2008 Aug;14(15):4883-90
    Schaue D et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 143
  • 文献情報:
    Chock KL et al. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Cancer Res. 2010 Nov;70(21):8782-91
    Chock KL et al
    2010/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 144
  • 文献情報:
    Min L et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 2012 Nov;14(11):1203-11
    Min L et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 145
  • 文献情報:
    Kim EY et al. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth. J. Immunol. 2009 Nov;183(10):6051-7
    Kim EY et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 146
  • 文献情報:
    Liu T et al. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells. Oncogene 2004 Jan;23(1):39-48
    Liu T et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 147
  • 文献情報:
    Gong J et al. Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells. Endocrinology 2007 Sep;148(9):4489-99
    Gong J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 148
  • 文献情報:
    Chen Y et al. Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells. Oncogene 2003 Aug;22(32):4964-72
    Chen Y et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 149
  • 文献情報:
    Maxia C et al. Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium. Mol. Vis. 2009;15:458-63
    Maxia C et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 150
  • 文献情報:
    Neef R et al. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol. 2003 Sep;162(5):863-75
    Neef R et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 151
  • 文献情報:
    Giodini A et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 2002 May;62(9):2462-7
    Giodini A et al
    2002/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 152
  • 文献情報:
    Rudkowski JC et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2004 Apr;286(4):L793-800
    Rudkowski JC et al
    2004/01/01
  • 備考:
    Species: Rat, Applications: WB
  • 参照:
    PubMed
  • No.: 153
  • 文献情報:
    Qanungo S et al. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002 Jun;21(26):4149-57
    Qanungo S et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 154
  • 文献情報:
    Guha M et al. Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res. 2009 Jun;69(12):4954-8
    Guha M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 155
  • 文献情報:
    Qi G et al. Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol. Rep. 2009 Sep;22(3):557-62
    Qi G et al
    2009/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 156
  • 文献情報:
    Gassmann R et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 2004 Jul;166(2):179-91
    Gassmann R et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 157
  • 文献情報:
    Knauer SK et al. An otoprotective role for the apoptosis inhibitor protein survivin. Cell Death Dis 2010;1:e51
    Knauer SK et al
    2010/01/01
  • 備考:
    Species: Guinea Pig, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 158
  • 文献情報:
    Sayeed A et al. IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels. PLoS ONE 2013;8(10):e76513
    Sayeed A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 159
  • 文献情報:
    Mahotka C et al. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ. 2002 Dec;9(12):1334-42
    Mahotka C et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 160
  • 文献情報:
    Li L et al. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Clin. Cancer Res. 2013 Dec;19(24):6703-15
    Li L et al
    2013/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 161
  • 文献情報:
    Vogt N et al. No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo. Leuk. Lymphoma 2014 Nov;:1-7
    Vogt N et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 162
  • 文献情報:
    Kang BH et al. Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem. 2006 Aug;281(34):24721-7
    Kang BH et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 163
  • 文献情報:
    Huang H et al. Tripin/hSgo2 recruits MCAK to the inner centromere to correct defective kinetochore attachments. J. Cell Biol. 2007 May;177(3):413-24
    Huang H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 164
  • 文献情報:
    Chen JS et al. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther. 2004 Nov;11(11):740-7
    Chen JS et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 165
  • 文献情報:
    Carvalho A et al. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell. Sci. 2003 Jul;116(Pt 14):2987-98
    Carvalho A et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 166
  • 文献情報:
    Xia F et al. A survivin-ran complex regulates spindle formation in tumor cells. Mol. Cell. Biol. 2008 Sep;28(17):5299-311
    Xia F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 167
  • 文献情報:
    Grabowski P et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br. J. Cancer 2003 Jan;88(1):115-9
    Grabowski P et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 168
  • 文献情報:
    Wimmershoff J et al. Immunohistochemical detection of survivin in canine lymphoma. J. Comp. Pathol. 2010 May;142(4):311-22
    Wimmershoff J et al
    2010/01/01
  • 備考:
    Species: Canine, Applications: IHC
  • 参照:
    PubMed
  • No.: 169
  • 文献情報:
    Wang F et al. Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation. J. Cell Biol. 2012 Oct;199(2):251-68
    Wang F et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 170
  • 文献情報:
    Xia M et al. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene 2011 Jan;30(3):346-55
    Xia M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 171
  • 文献情報:
    Honda R et al. Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 2003 Aug;14(8):3325-41
    Honda R et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 172
  • 文献情報:
    Geddis AE et al. Megakaryocytes express functional Aurora-B kinase in endomitosis. Blood 2004 Aug;104(4):1017-24
    Geddis AE et al
    2004/01/01
  • 備考:
    Species: Mouse, Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 173
  • 文献情報:
    Schlette EJ et al. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J. Clin. Oncol. 2004 May;22(9):1682-8
    Schlette EJ et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 174
  • 文献情報:
    Kabbarah O et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 2010;5(5):e10770
    Kabbarah O et al
    2010/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 175
  • 文献情報:
    Gould Rothberg BE et al. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 2009 Apr;101(7):452-74
    Gould Rothberg BE et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 176
  • 文献情報:
    Connell CM et al. Nuclear survivin has reduced stability and is not cytoprotective. J. Biol. Chem. 2008 Feb;283(6):3289-96
    Connell CM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 177
  • 文献情報:
    Wang Z et al. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol. Cancer Ther. 2013 May;12(5):759-67
    Wang Z et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 178
  • 文献情報:
    Fukuda S et al. Survivin, a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 2006 May;5(5):1087-98
    Fukuda S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 179
  • 文献情報:
    Jiang X et al. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin. Cancer Res. 2008 Dec;14(23):7726-32
    Jiang X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 180
  • 文献情報:
    Kennedy SM et al. Prognostic importance of survivin in breast cancer. Br. J. Cancer 2003 Apr;88(7):1077-83
    Kennedy SM et al
    2003/01/01
  • 備考:
    Species: Human, Applications: IHC-Fr, IHC-P
  • 参照:
    PubMed
  • No.: 181
  • 文献情報:
    Hata T et al. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Mol. Cancer Ther. 2005 Oct;4(10):1585-94
    Hata T et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 182
  • 文献情報:
    Knauer SK et al. Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J. 2007 Jan;21(1):207-16
    Knauer SK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 183
  • 文献情報:
    Chen JG et al. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 2003 Nov;63(22):7891-9
    Chen JG et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 184
  • 文献情報:
    Lu H et al. The Expression and Role of MEKK3 in Renal Clear Cell Carcinoma. Anat Rec (Hoboken) 2014 Nov;
    Lu H et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 185
  • 文献情報:
    Mao JT et al. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin. Cancer Res. 2006 Jan;12(1):314-20
    Mao JT et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 186
  • 文献情報:
    Caldas H et al. Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 2007 Feb;109(4):1479-89
    Caldas H et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 187
  • 文献情報:
    Tecleab A et al. Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle 2013 Feb;12(3):522-32
    Tecleab A et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IP
  • 参照:
    PubMed
  • No.: 188
  • 文献情報:
    Khan S et al. Survivin is released from cancer cells via exosomes. Apoptosis 2011 Jan;16(1):1-12
    Khan S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 189
  • 文献情報:
    Krysan K et al. COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J. 2004 Jan;18(1):206-8
    Krysan K et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 190
  • 文献情報:
    Xia F et al. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 2008 Mar;68(6):1826-33
    Xia F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 191
  • 文献情報:
    Fortugno P et al. Regulation of survivin function by Hsp90. Proc. Natl. Acad. Sci. U.S.A. 2003 Nov;100(24):13791-6
    Fortugno P et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 192
  • 文献情報:
    O"Connor DS et al. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2002 Jul;2(1):43-54
    O"Connor DS et al
    2002/01/01
  • 備考:
    Species: Human, Applications: WB, IP
  • 参照:
    PubMed
  • No.: 193
  • 文献情報:
    Lo Muzio L et al. Survivin expression in oral squamous cell carcinoma. Br. J. Cancer 2003 Dec;89(12):2244-8
    Lo Muzio L et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 194
  • 文献情報:
    Ghosh JC et al. Hsp60 regulation of tumor cell apoptosis. J. Biol. Chem. 2008 Feb;283(8):5188-94
    Ghosh JC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed